| 跨国制药企业加大在华研发投资的动因及其影响 |
| |
| 引用本文： | 洪兰,李野,赵健. 跨国制药企业加大在华研发投资的动因及其影响[J]. 中国药房, 2005, 16(9): 653-655 |
| |
| 作者姓名： | 洪兰 李野 赵健 |
| |
| 作者单位： | 沈阳药科大学工商管理学院,沈阳市,110016 |
| |
| 摘 要： | 目的为提高我国医药产业技术水平和研发能力提供参考。方法分析和探讨跨国制药企业在华研发投资现状及加大在华研发投资的动因和影响,并提出我国应对这一国际经济形势的对策和建议。结果与结论在跨国制药企业加大在华研发投资的背景下,我国应该趋利避害,在坚持自主创新的同时,加强国际合作,从而促进我国医药产业的发展。
|
| 关 键 词： | 跨国制药企业 研发 投资 |
| 文章编号： | 1001-0408(2005)09-0653-03 |
| 修稿时间： | 2004-12-07 |
Motive and Impact of Multinational Pharmaceutical Enterprises'''' Increased Investment in Research & Development in China |
| |
| Hong Lan,LI Ye,ZHAO Jian. Motive and Impact of Multinational Pharmaceutical Enterprises'''' Increased Investment in Research & Development in China[J]. China Pharmacy, 2005, 16(9): 653-655 |
| |
| Authors: | Hong Lan LI Ye ZHAO Jian |
| |
| Abstract: | OBJECTIVE:To provide references for how to enhance industrial technical level and research&development ability.METHODS:The status quo of the research&development and the investment of the multinational pharmaceutical enterprises in China,and the motive and impact of their increased investment in China were studied and analyzed.Some countermeasures and recommendations in coping with the international economical situation were presented.RESULTS&CONCLUSION:Under the situation of increasing investment on research&development in china by multinational pharma-ceutical enterprises,we should take advantage of the positive effects and avoid the negative effects,insist on independence and innovation meanwhile enhance international cooperation so as to promote the development of Chinese pharmaceutical indus-tries. |
| |
| Keywords: | Multinational pharmaceutical enterprises Research & development Investment |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
